Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SULFORAPHANE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | SULFORAPHANE |
| Key Genes/Proteins | AKT, AQP4, BDNF, CREB, ERK, HDAC2 |
| Related Diseases | ALZHEIMER, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AUTOPHAGY, CHOLESTEROL |
Knowledge base pages for this entity
graph TD
SULFORAPHANE["SULFORAPHANE"]
SULFORAPHANE -->|"activates"| TFEB["TFEB"]
SULFORAPHANE -->|"activates"| lipophagy["lipophagy"]
SULFORAPHANE -->|"activates"| AMPK["AMPK"]
SULFORAPHANE -->|"mediates"| TFEB_Nuclear_Translocation["TFEB Nuclear Translocation"]
SULFORAPHANE -->|"treats"| Oxidative_Stress["Oxidative Stress"]
SULFORAPHANE -->|"contributes to"| LC3["LC3"]
SULFORAPHANE -->|"inhibits"| Neuroinflammation["Neuroinflammation"]
SULFORAPHANE -->|"suppresses"| OXIDATIVE_STRESS["OXIDATIVE STRESS"]| Target | Relation | Type | Str |
|---|---|---|---|
| h-5050522d | targeted_by | hypothesis | 1.00 |
| TFEB | activates | protein | 0.95 |
| AMPK | activates | protein | 0.90 |
| Aβ accumulation | inhibits | process | 0.90 |
| Tau hyperphosphorylation | inhibits | process | 0.90 |
| lipophagy | activates | pathway | 0.90 |
| TFEB Nuclear Translocation | mediates | mechanism | 0.88 |
| Oxidative Stress | treats | disease | 0.85 |
| GSK3B | activates | gene | 0.85 |
| LC3 | contributes_to | protein | 0.80 |
| Neuroinflammation | inhibits | process | 0.80 |
| KL | modulates | gene | 0.75 |
| OXIDATIVE STRESS | suppresses | process | 0.75 |
| NRF2 | activates | protein | 0.70 |
| cerebral ischemia/reperfusion injury | treats | disease | 0.70 |
| ASTROCYTES | protects_against | cell_type | 0.70 |
| ASTROCYTES | activates | cell_type | 0.70 |
| OXIDATIVE STRESS | activates | phenotype | 0.65 |
| ISCHEMIA | activates | disease | 0.65 |
| TAU | inhibits | protein | 0.65 |
| BDNF | phosphorylates | gene | 0.65 |
| BDNF | regulates | gene | 0.65 |
| HDAC2 | inhibits | gene | 0.65 |
| BDNF | associated_with | gene | 0.65 |
| AQP4 | protects_against | gene | 0.65 |
| AQP4 | regulates | gene | 0.65 |
| BDNF | activates | gene | 0.65 |
| BDNF | expressed_in | gene | 0.55 |
| MAPK | associated_with | gene | 0.50 |
| AUTOPHAGY | associated_with | phenotype | 0.50 |
| KEAP1 | associated_with | gene | 0.50 |
| HMOX1 | associated_with | gene | 0.50 |
| LAMP1 | associated_with | gene | 0.50 |
| TFEB | associated_with | gene | 0.50 |
| HO-1 | associated_with | gene | 0.50 |
| ROS | associated_with | phenotype | 0.50 |
| MTOR | associated_with | gene | 0.50 |
| ASTROCYTES | associated_with | cell_type | 0.50 |
| ASTROCYTE | associated_with | cell_type | 0.50 |
| NRF2 | associated_with | gene | 0.50 |
| QUERCETIN | associated_with | drug | 0.45 |
| DASATINIB | associated_with | drug | 0.45 |
| RAPAMYCIN | associated_with | drug | 0.45 |
| ISCHEMIA | associated_with | disease | 0.45 |
| ERK | associated_with | gene | 0.45 |
| HDAC2 | associated_with | gene | 0.45 |
| CHOLESTEROL | associated_with | phenotype | 0.45 |
| AQP4 | associated_with | gene | 0.45 |
| TREM2 | associated_with | gene | 0.45 |
| CURCUMIN | associated_with | drug | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-5050522d | targets | hypothesis | 1.00 |
| 41894075 | improves | paper | 0.90 |
| 41894075 | activates | paper | 0.90 |
| 41894075 | modulates | paper | 0.90 |
| 41894075 | suppresses | paper | 0.90 |
| 41894075 | mitigates | paper | 0.90 |
| 41894075 | attenuates | paper | 0.90 |
| 41894075 | preserves | paper | 0.90 |
| 41894075 | inhibits | paper | 0.90 |
| 41894075 | represents potential for | paper | 0.60 |
| ATHEROSCLEROSIS | associated_with | disease | 0.50 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.50 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.45 |
| N-ACETYLCYSTEINE | associated_with | drug | 0.45 |
| HMGB1 | associated_with | gene | 0.45 |
| RESVERATROL | associated_with | drug | 0.45 |
| SIRT1 | associated_with | gene | 0.45 |
| STING | associated_with | gene | 0.45 |
| BDNF | associated_with | gene | 0.45 |
| CURCUMIN | associated_with | drug | 0.45 |
| NEURONS | associated_with | cell_type | 0.45 |
| AKT | associated_with | gene | 0.45 |
| CREB | associated_with | gene | 0.45 |
| ERK | associated_with | gene | 0.45 |
| HDAC2 | associated_with | gene | 0.45 |
| ALZHEIMER | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio | 0.838 | neurodegeneration | View |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Sequential DFO + Sulforaphane Prevents Iron-Ferroptosis Cascade in Rat | in_vivo | post-cardiac-arrest neurodegen | 0.768 | 0.72 | Sprague-Dawley rat asphyxial c | proposed | $48,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SULFORAPHANE in their description or question text
No additional research found